Smarttech247 Group PLC (AIM: S247) plans to delist from London’s AIM market, citing high costs, regulatory burdens, and undervaluation. The Dublin-based cybersecurity company saw its share price fall about 71%
European Green Transition (AIM: EGT) Interim results and M&A strategy update
European Green Transition (AIM: EGT), a company which aims to capitalise on the opportunities created by the green energy transition in Europe, announces its unaudited results for the six months
N4 Pharma plc (AIM: N4P) Partnership with University of Strathclyde’s CMAC National Facility
Collaboration combines N4 Pharma’s innovative Nuvec® delivery platform with CMAC’s world-class expertise to accelerate development and broaden therapeutic applications
hVIVO plc – Unaudited Interim Results for Six Months Ended 30 June 2025
Interim results Trading in line with expectations for full year Returning to growth in 2026
Breakthrough in Targeted Cancer Treatment Sends N4 Pharma Stock Soaring
N4 Pharma PLC (AIM: N4P) shares surged after the company announced that its Nuvec® delivery system had successfully targeted non-small cell lung cancer cells in collaboration with leading US research
European Green Transition: From Exploration to Execution at The Investor Summit
A Company in Transition
hVIVO plc (AIM: HVO) Appointment of Non-Executive Chair
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that, further to its announcement on 29 July 2025, Shaun
hVIVO plc (AIM: HVO) Proposed appointment of Chair
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation and the world leader in human challenge clinical trials, announces the appointment of Shaun Chilton as Non-Executive Chair, subject to successful completion of
hVIVO PLC (AIM:HVO) Notice of Trading Update
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that it will issue a trading update for the six months ended 30
The economic case for medicinal cannabis
In the last few years, it has become increasingly evident that medicinal cannabis is not only revolutionising the way we manage specific health issues, it’s also quietly transforming the economic
hVIVO PLC (AIM:HVO) Positive results from client Phase 2b field study
Positive topline results from client Phase 2b field study
European Green Transition: From Exploration to Execution as Cathal Friel Takes the Helm
European Green Transition plc (AIM: EGT) recently released its audited results for the year ended 31 December 2024, marking a pivotal period of transformation for the green economy investment company.